FDA Adverse Event Malfunction Summary report: N

I-STAT CHEM8+ CARTRIDGE

MDR report key: 23980903 · Received January 6, 2026

Report

Report Number
2245578-2026-00005
Event Type
Malfunction
Date Received
January 6, 2026
Date of Event
December 23, 2025
Report Date
January 30, 2026
Manufacturer
ABBOTT POINT OF CARE
Product Code
JPI
PMA / PMN Number
K183680
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Additional Manufacturer Narrative · 0

APOC INCIDENT: (B)(4). THE INVESTIGATION WAS COMPLETED ON 28-JAN-2026. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS RELEASE CRITERIA. RETAINED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. AP, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN DETERMINED FOR CHEM8+ CARTRIDGE LOT H25232.

Description of Event or Problem · 0

ON 29-DEC-2025, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CHEM8+ CARTRIDGE THAT YIELDED A DISCREPANT HEMATOCRIT RESULT ON AN A PATIENT. THERE WAS NO PATIENT INFORMATION AT THE TIME OF THIS REPORT. RETURN PRODUCT IS AVAILABLE FOR INVESTIGATION. METHOD DATE COLLECTED TESTED HGB HCT K SAMPLE I-STAT (B)(6) 2025 NI 10:30 21.8 G/DL 64%. 6.2 MMOL/L A, WB IN LI HRPARIN BECKMAN (B)(6) 2025 11:25 11:43 9.9 G/DL 30.7% NI B, WB IN LAVENDER TOP ORTHO (B)(6) 2025 11:25 12:01 NI NI 4.9 MMOL/L C, GOLD TOP SERUM AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTED THAT PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY. THE INVESTIGATION IS UNDERWAY.

Description of Event or Problem · 0

NA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
237844 I-STAT CHEM8+ CARTRIDGE CHEM8+ CARTRIDGE JPI ABBOTT POINT OF CARE NA H25232

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown